Replies to post #130641 on Biotech Values

[go seek]

when that injuction is lifted

Most do not see that happening... the more likely path is a settlement or trial decision.

[DewDiligence]

While I wouldn't buy after the recent news and pop – when that injunction is lifted and it sells off it would make a lot of sense to pick it up…

That’s not a sensible approach to acquiring shares unless you are uncommonly patient.* If not overturned on appeal, the preliminary injunction against Amphastar will likely persist for a couple of years because that’s how long it will probably take for the patent trial to be completed.

*Based on my knowing you for almost a decade, I would say that patience is not an apt description of your investing style :- )

[joethdo]

I would argue that the probability that you will be able to buy MNTA lower than 14 or 15 is much lower than the probability you will have to buy it higher, perhaps much higher.

Are you waiting to buy it when MNTA's cash equals its market cap?

[jb_118]

While I wouldn't buy after the recent news and pop - when that injuction is lifted and it sells off it would make a lot of sense to pick it up

I'm not expecting the injunction to be lifted on appeal, as Amphastar didn't mount much of a defense in the first place.

Your better entry point might be when the full impact of the AG on Q4 and future earnings are realized (the hybrid royalty/profit share is now priced in...what isn't is the extent of price/market share erosion).